DalCor Pharmaceuticals Funding: $80M Raised, Series D (2023)

DalCor Pharmaceuticals funding overview

DalCor Pharmaceuticals is based in Montreal, Canada. DalCor Pharmaceuticals has raised $80M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in September 2023. The round record for DalCor Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Fonds de Developpement Économique, Investissement Québec, Fonds Propres d’ Investissement Québec, Andes Growth, TB Pharma, Fonds de Solidarité FTQ and 1 others. 7 distinct backers are named across the disclosed rounds.

DalCor Pharmaceuticals at a glance

Total raised: $80M
Latest round: Series D
Latest round date: September 2023
Headquarters: Montreal, Canada
Notable investors: Fonds de Developpement Économique, Investissement Québec, Fonds Propres d’ Investissement Québec, Andes Growth, TB Pharma, Fonds de Solidarité FTQ, CTI Life Sciences

Frequently asked about DalCor Pharmaceuticals funding

How much has DalCor Pharmaceuticals raised?: DalCor Pharmaceuticals has raised $80M in total disclosed funding across the rounds on record.
Who has invested in DalCor Pharmaceuticals?: Fonds de Developpement Économique, Investissement Québec, Fonds Propres d’ Investissement Québec, Andes Growth, TB Pharma, Fonds de Solidarité FTQ are named among the investors backing DalCor Pharmaceuticals.
What was the latest DalCor Pharmaceuticals funding round?: The most recent disclosed round is a Series D, announced in September 2023.
Where is DalCor Pharmaceuticals based?: DalCor Pharmaceuticals is based in Montreal, Canada.
When did DalCor Pharmaceuticals last raise?: The last disclosed DalCor Pharmaceuticals round closed in September 2023 at Series D.

DalCor Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Montreal below to benchmark round size and investor mix.

DalCor Pharmaceuticals Funding: $80M Raised, Series D (2023)

DalCor Pharmaceuticals funding overview

DalCor Pharmaceuticals at a glance

Frequently asked about DalCor Pharmaceuticals funding

Companies related to DalCor Pharmaceuticals (18)

Browse related funding lists (4)